Company intelligence / Profile preview

Optain

Ownership: Private
Development stage: Other

Overview

Optain is a global medical device and software company specializing in AI-powered retinal imaging. Its technology enables early detection of eye and systemic diseases through advanced image analysis. The company's roots trace back to Eyetelligence Pty Ltd, founded in Australia in 2019.

Therapeutic areas: OphthalmologyCardiovascular
Modalities: DeviceSoftware/AI-enabled diagnostics (not a therapeutic modality, but relevant to healthcare diagnostics)
Industry: Medical Imaging

Beyond the preview

Go deeper on Optain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optain.

Explore the full profile